Penicillin and essential fatty acid supplementation in schizophrenia

Prostaglandines and Medicine

Volumn 2, Issue 1, 1979, Pages 77-80

  Vaddadi, K S ^a  

^a BOOTHAM PARK HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

1 ACETYL 2 (8 CHLORO 10,11 DIHYDRODIBENZ[B,F][1,4]OXAZEPINE 10 CARBONYL)HYDRAZINE; CHLORPROMAZINE; CLOZAPINE; ESSENTIAL FATTY ACID; FLUPHENAZINE DECANOATE; PENICILLIN G; PROSTAGLANDIN; TRIFLUOPERAZINE; TRIHEXYPHENIDYL;

CLINICAL STUDY; DRUG THERAPY; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; SCHIZOPHRENIA; THERAPY;

ADULT; CASE REPORT; FATTY ACIDS, ESSENTIAL; FEMALE; HUMAN; MALE; PENICILLIN V; SCHIZOPHRENIA;

EID: 0018770327     PISSN: 01614630     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-4630(79)80011-7     Document Type: Article

References (7)

1. Schizophrenia as a prostaglandin deficiency disease
2. Prostaglandins and schizophrenia: further discussion of the evidence
3. An antipsychotic effect of penicillin in schizophrenia
4. Neuropharmacological and behavioral evaluation of prostaglandin E2 and 11-thiol-11-desoxy prostaglandin E2 in the mouse and rat
5. The desaturation step in the animal biosynthesis of polyunsaturated fatty acids